Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Pike

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
International Journal of Antimicrobial Agents|November 3, 2004
Characterisation of viridans group streptococci with different levels of Tet(M)-mediated tetracycline resistancePaul Stapleton, Victoria Adams, Rachel Pike, et al.
FEMS Microbiology Letters|April 25, 2006
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumanniiJane F Turton, M Elaina Ward, Neil Woodford, et al.
Journal of Medical Microbiology|May 3, 2017
Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patientsDervla T D Kenna, Daniel Lilley, Amy Coward, et al.
Manual Therapy|August 7, 2016
Effects of dry needling to the symptomatic versus control shoulder in patients with unilateral subacromial pain syndromeShane Koppenhaver, Robin Embry, John Ciccarello, et al.
Journal of Clinical Microbiology|April 12, 2013
Use of faropenem as an indicator of carbapenemase activity in the EnterobacteriaceaeKathryn M Day, Rachel Pike, Trevor G Winstanley, et al.
The Journal of Antimicrobial Chemotherapy|May 19, 2017
Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British IslesDavid M Livermore, Shazad Mushtaq, Daniele Meunier, et al.
The Journal of Antimicrobial Chemotherapy|April 29, 2014
NDM carbapenemases in the United Kingdom: an analysis of the first 250 casesAnu Jain, Katie L Hopkins, Jane Turton, et al.
The Journal of Antimicrobial Chemotherapy|February 16, 2017
OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014Jacqueline Findlay, Katie L Hopkins, Richard Loy, et al.
Microbial Genomics|September 11, 2025
Dissemination of OXA-23 carbapenemase-producing <i>Proteus mirabilis</i> and <i>Escherichia coli</i> is driven by transposon-carrying lineages in the UKRoxana Zamudio, Karen Osman, Rachel Pike, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2010
Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patientsRobert L R Hill, Angela M Kearns, James Nash, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
International Journal of Antimicrobial Agents|November 3, 2004
Characterisation of viridans group streptococci with different levels of Tet(M)-mediated tetracycline resistancePaul Stapleton, Victoria Adams, Rachel Pike, et al.
FEMS Microbiology Letters|April 25, 2006
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumanniiJane F Turton, M Elaina Ward, Neil Woodford, et al.
Journal of Medical Microbiology|May 3, 2017
Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patientsDervla T D Kenna, Daniel Lilley, Amy Coward, et al.
Manual Therapy|August 7, 2016
Effects of dry needling to the symptomatic versus control shoulder in patients with unilateral subacromial pain syndromeShane Koppenhaver, Robin Embry, John Ciccarello, et al.
Journal of Clinical Microbiology|April 12, 2013
Use of faropenem as an indicator of carbapenemase activity in the EnterobacteriaceaeKathryn M Day, Rachel Pike, Trevor G Winstanley, et al.
The Journal of Antimicrobial Chemotherapy|May 19, 2017
Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British IslesDavid M Livermore, Shazad Mushtaq, Daniele Meunier, et al.
The Journal of Antimicrobial Chemotherapy|April 29, 2014
NDM carbapenemases in the United Kingdom: an analysis of the first 250 casesAnu Jain, Katie L Hopkins, Jane Turton, et al.
The Journal of Antimicrobial Chemotherapy|February 16, 2017
OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014Jacqueline Findlay, Katie L Hopkins, Richard Loy, et al.
Microbial Genomics|September 11, 2025
Dissemination of OXA-23 carbapenemase-producing <i>Proteus mirabilis</i> and <i>Escherichia coli</i> is driven by transposon-carrying lineages in the UKRoxana Zamudio, Karen Osman, Rachel Pike, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2010
Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patientsRobert L R Hill, Angela M Kearns, James Nash, et al.
Pageof 4